Invesco S&P 500 Equal Weight Health Care ETF

Eli Lilly Announces Phase III Results for Jaypirca Combination: 45% Risk Reduction in CLL Patients

Eli Lilly Announces Early Phase 1 Results for AJ1-11095 in Myelofibrosis Treatment

Humana to Sell Minority Stake in Gentiva for Approximately $900 Million

O'Neill Partners with Eli Lilly to Launch Campaign Promoting Zepbound for Sleep Apnea

Elevance Health Reaffirms 2026 Fiscal Year Diluted EPS Guidance of at Least $19.85

Jefferies Raises Eli Lilly Price Target from $1330 to $1350

Eli Lilly's Ebglyss Approved by FDA for Every-8-Weeks Maintenance Therapy

Barclays Upgrades Cigna to Overweight, Raises Target to $400, Driving Stock Price Higher

Roche Confirms €600M German Diagnostic Center Investment, Contrasting with Competitors' Cuts

Eli Lilly reports superior Phase 3 results for orforglipron, plans to submit NDA to FDA

AlzeCure Pharma and Eli Lilly Reach Over $1 Billion Alzheimer's Project Deal

DaVita Signs Credit Agreement Amendment with JPMorgan and Adds $500M to Term Loan

ACHIEVE Trial Releases: Orforglipron Shows Superiority in Head-to-Head Study for Glycemic Control and Weight Management

JPMorgan Raises UnitedHealth Target to $466 as Stock Hits 52-Week High

Mizuho Raises Health Target Price Target from $440 to $460

Eli Lilly Reports Strong Late-Stage Trial Results for Three Weight Loss and Diabetes Drugs and Plans Global Submissions

Eli Lilly Invests $3.8 Billion to Acquire Three Vaccine Companies

Phase 3 Study Shows Retatrutide Therapy Reduces Obesity Weight by Up to 28.3% and Improves Diabetes Control

Retatrutide Phase 3 Trial Results Announced: Type 2 Diabetes Patients Lost Average of 36.6 Pounds

Freecast

Cuprina

U-BX Tech

HORIZON SPACE ACQUISITION II CORP COM USD0.0001 30/03/2026(SUB/RIGHTS)

Defiance Pure Space Dly 2X Strat ETF

VS MEDIA

Everbright Digital

Park Ha Biological Tech

Friedman Industries

Defiance Daily Target 2X Short ASTS ETF

RSPH

State Street's Health Care Select Sector SPDR ETF (XLV) outperforms Invesco's Equal Weight Health Care ETF (RSPH) in yield and returns. XLV offers a lower expense ratio (0.08% vs 0.4%), higher dividend yield (1.72% vs 0.7%), and better total returns over one and five years, alongside lower maximum drawdown. While RSPH uses equal weighting for diversification, XLV's market-cap weighting provides stability and income focus.

nasdaq

Health Care Select Sector SPDR

S&P 500

Eli Lilly

Johnson & Johnson

Abbvie

Humana

Centene

Elevance Health

State Street

Invesco

State Street® US Equity Premium Inc ETF

State Street's Health Care ETF Tops Invesco's on Yield and Returns

HIMS

HIMY

This week, Wall Street saw declines, particularly in technology stocks, while the S&P 500 Health Care Index gained 1.09%. Notable healthcare news includes UnitedHealth's new pharmacy pricing model set for 2027, a $15.2B licensing deal between Bristol Myers Squibb and Hengrui Pharma, and Hims & Hers Health reporting disappointing Q1 results. Additionally, concerns were raised about the potential impact of Trump's drug policy on US biopharma innovation.

businessinsider

Bristol Myers Squibb

Hims & Hers Health

Defiance Leveraged Long +Income HIMS ETF

Direxion Pharma & Medical Bull 3X

iShares Biotechnology ETF

ALPS Medical Breakthrough

Direxion S&P Biotech Bull 3X

First Trust NYSE Arca Biotech Index Fd

Defiance Daily Target 2X Long HIMS ETF

VanEck Biotech ETF

iShares US Medical Devices

iShares Global Healthcare

VG Health

Ark Genomic Revolution ETF

Invesco Nasdaq Biotechnology ETF

ProShares Ultra Health Care ETF

SPDR S&P Health Equip

iShares US Healthcare Providers

SPDR S&P Biotech

Invesco Biotechnology & Genome ETF

Notable healthcare headlines for the week: UnitedHealth, Bristol Myers Squibb, and Hims & Hers in focus

CURE

Molina Healthcare shareholders approved governance and bylaw changes at the May 6, 2026 annual meeting. Key amendments allow stockholders with at least 20% voting power to call special meetings. The board adopted new bylaws detailing procedural safeguards. Shareholders elected ten directors, ratified Ernst & Young as auditor, and increased shares under the 2025 Equity Incentive Plan. The latest analyst rating for MOH stock is a Buy with a $250 price target, though concerns about recent fundamentals and valuation persist. Molina Healthcare focuses on providing health insurance to low-income populations.

Tip Ranks

Molina Healthcare

Direxion Healthcare Bull 3X

SPDR S&P Health

Molina Healthcare Shareholders Approve Governance and Bylaw Changes

Centric Wealth Management has reduced its stake in Molina Healthcare, Inc (NYSE:MOH) by 74.3%, now holding 3,100 shares valued at $562,000. Other institutional investors have also adjusted their positions in the company. Molina Healthcare's stock opened at $186.07, with a market cap of $9.69 billion and a PE ratio of 55.05. Analysts have mixed ratings on the stock, with a consensus rating of "Hold" and an average price target of $169.60. The company specializes in government-sponsored health insurance programs.

Market Beat

Rakuten Group, Inc.

Mizuho Financial Group, Inc.

Mizuho Financial

Deutsche Bank AG

Goldman Sachs

Deutsche Bank AG Subscription Rights

Deutsche Postbank AG

GS Hldg R

Centric Wealth Management Cuts Stock Position in Molina Healthcare, Inc $MOH

Wall Street's major indices rose on Friday, with the S&P 500 Health Care Index slipping 1.15% for the week. Notable healthcare news includes UnitedHealthcare's plan to cut prior authorization requirements by 30%, Pfizer's Q1 results exceeding estimates, and Amazon's launch of Novo Nordisk's Ozempic pill for same-day delivery. CVS Health shares surged over 7% after raising its full-year outlook, while Angelini Pharma announced its acquisition of Catalyst Pharmaceuticals for $4.1B. The healthcare sector remains dynamic amid these developments.

Pfizer

CVS Health

Unitedhealth

iShares US Pharma

Notable healthcare headlines for the week: UnitedHealth, Pfizer, and CVS Health in focus

Molina Healthcare Inc. (MOH) shares fell 1.72% to $192.17 on Tuesday, underperforming against competitors despite a positive market day, with the S&P 500 up 0.81%. The stock is currently 42.29% below its 52-week high of $333.00. Competitors Humana Inc. (HUM) and Centene Corp. (CNC) had mixed performances, with Humana rising 0.66% and Centene falling 1.08%. Trading volume was below the 50-day average.

MarketWatch Automated

Dow Jones Industrial Average

Molina Healthcare Inc. Stock Underperforms Tuesday When Compared To Competitors

SPXV

Molina Healthcare Inc. (MOH) shares rose 1.47% to $195.53 on Monday, despite a declining stock market, with the S&P 500 down 0.41% and the Dow Jones down 1.13%. The stock's increase ended a two-day losing streak but remains 41.28% below its 52-week high of $333.00. Compared to competitors, Molina underperformed as Humana Inc. rose 1.85% and Centene Corp. rose 0.41%. Trading volume was significantly below the 50-day average.

Pro S&P 500 Ex-Hlth

Factset Research

Molina Healthcare Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Cwm LLC reduced its stake in Molina Healthcare, Inc (NYSE:MOH) by 95.4% in Q4, holding 3,522 shares valued at $611,000, according to its recent SEC filing. Other institutional investors also adjusted their positions, with Blue Trust Inc. increasing its stake by 23.8%. Molina Healthcare's stock opened at $194.79, with a market cap of $10.15 billion and a P/E ratio of 57.63. Analysts have mixed ratings on the stock, with target prices ranging from $129.00 to $220.00.

Cwm LLC Has $611,000 Stock Holdings in Molina Healthcare, Inc $MOH

Molina Healthcare Inc. (MOH) shares rose 3.48% to $185.46 on a challenging trading day for the market, marking its ninth consecutive day of gains. Despite this, the stock remains 44.31% below its 52-week high of $333.00. Competitors Humana Inc. (HUM) and Centene Corp. (CNC) also saw gains of 2.73% and 13.95%, respectively. Trading volume for Molina was 2.1 million, surpassing its 50-day average of 1.7 million.

Molina Healthcare Inc. Stock Outperforms Competitors On Strong Trading Day

Molina Healthcare shares are trading higher after the company reported better-than-expected Q1 adjusted EPS results.

benzinga_article

Invesco S&P 500 Equal Weight Health Care ETF(RSPH.US)

State Street's Health Care ETF Tops Invesco's on Yield and Returns

Notable healthcare headlines for the week: UnitedHealth, Bristol Myers Squibb, and Hims & Hers in focus

Molina Healthcare Shareholders Approve Governance and Bylaw Changes

Centric Wealth Management Cuts Stock Position in Molina Healthcare, Inc $MOH

Notable healthcare headlines for the week: UnitedHealth, Pfizer, and CVS Health in focus